CYTOSORBENTS CORPORATION Retained Earnings
CYTOSORBENTS CORPORATION (CTSO) had Retained Earnings of -$321.75 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$321.75M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$317.34M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$312.21M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$306.71M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$321.75M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$317.34M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$312.21M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$306.71M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$303.54M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$305.49M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$304.01M 10-K · filed 2026-03-30 | -$304.01M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$296.44M 10-K · filed 2025-03-31 | -$295.34M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$293.67M 10-K · filed 2025-03-31 | -$293.01M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$289.38M 10-K · filed 2025-03-31 | -$288.86M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$283.29M 10-K · filed 2025-03-31 | -$282.51M 10-K · filed 2024-03-15 |
| 2023-09-30 | -$277.14M 10-K · filed 2025-03-31 | -$276.67M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$267.97M 10-K · filed 2025-03-31 | -$267.48M 10-Q · filed 2023-08-01 |
| 2023-03-31 | -$261.36M 10-K · filed 2025-03-31 | -$261.32M 10-Q · filed 2023-05-02 |
| 2022-12-31 | -$254.00M 10-K · filed 2024-03-15 | |
| 2022-09-30 | -$253.23M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | -$241.03M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | -$230.15M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | -$221.19M 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$211.88M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$205.47M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | -$200.79M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | -$196.63M 10-K · filed 2022-03-10 | |
| 2020-09-30 | -$195.95M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | -$195.11M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | -$192.24M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | -$188.79M 10-K · filed 2021-03-09 | |
| 2019-09-30 | -$184.84M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | -$177.96M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | -$174.41M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | -$169.52M 10-K · filed 2020-03-05 | |
| 2018-09-30 | -$164.12M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | -$161.12M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | -$155.29M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | -$152.31M 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$149.17M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$146.96M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | -$145.84M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$143.52M 10-K · filed 2018-03-08 | -$144.46M 10-K · filed 2017-03-03 |
| 2016-09-30 | -$140.05M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | -$137.37M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$134.36M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$132.53M 10-K · filed 2017-03-03 | |
| 2015-09-30 | -$130.52M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$127.68M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | -$129.11M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$124.39M 10-K · filed 2016-03-09 | |
| 2014-09-30 | -$113.90M 10-Q · filed 2014-11-12 | |
| 2013-12-31 | -$105.81M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |